Guide to Biosimilars Litigation and Regulation in the U.S.

Guide to Biosimilars Litigation and Regulation in the U.S.
Author :
Publisher :
Total Pages : 0
Release :
ISBN-10 : 1731923759
ISBN-13 : 9781731923752
Rating : 4/5 (752 Downloads)

Book Synopsis Guide to Biosimilars Litigation and Regulation in the U.S. by :

Download or read book Guide to Biosimilars Litigation and Regulation in the U.S. written by and published by . This book was released on 2022 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Guide to Biosimilars Litigation and Regulation in the U.S. Related Books

Guide to Biosimilars Litigation and Regulation in the U.S.
Language: en
Pages: 0
Authors:
Categories: Drugs
Type: BOOK - Published: 2022 - Publisher:

DOWNLOAD EBOOK

Guide to Biosimilars Litigation and Regulation in the U.S.
Language: en
Pages: 0
Authors:
Categories: Drugs
Type: BOOK - Published: 2023 - Publisher:

DOWNLOAD EBOOK

Making Medicines Affordable
Language: en
Pages: 235
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Medical
Type: BOOK - Published: 2018-03-01 - Publisher: National Academies Press

DOWNLOAD EBOOK

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were
Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade
Language: en
Pages: 259
Authors: World Intellectual Property Organization
Categories: Law
Type: BOOK - Published: 2013 - Publisher: WIPO

DOWNLOAD EBOOK

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in develop
WHO guideline on country pharmaceutical pricing policies
Language: en
Pages: 70
Authors:
Categories: Business & Economics
Type: BOOK - Published: 2020-09-29 - Publisher: World Health Organization

DOWNLOAD EBOOK

In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmac